Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts

Stoner, 1995, Polyphenols as cancer chemopreventive agents, J. Cell. Biochem., 22, 169, 10.1002/jcb.240590822

Fujiki, 1996, Japanese green tea as a cancer preventive agent in humans, Nutr. Rev., 54, S67, 10.1111/j.1753-4887.1996.tb03821.x

Huang, 1992, Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin, Carcinogenesis, 13, 947, 10.1093/carcin/13.6.947

Fujiki, 1992, Anticarcinogenic effects of (−)-epigallocatechin gallate, Prev. Med., 4, 503, 10.1016/0091-7435(92)90057-O

Hirose, 1997, Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague–Dawley rats pretreated with 7,12 dimethylbenz(a)anthracene, Cancer Lett., 112, 141, 10.1016/S0304-3835(96)04560-0

Liao, 1995, Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate, Cancer Lett., 25, 239, 10.1016/0304-3835(95)03948-V

Achiwa, 1997, Inhibitory effects of persimmon (Diospyros kaki) extract and related polyphenol compounds on growth of human lymphoid leukemia cells, Biosci. Biotechnol. Biochem., 61, 1099, 10.1271/bbb.61.1099

Asano, 1997, Effect of (−)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia, Life Sci., 60, 135, 10.1016/S0024-3205(96)00603-0

Lea, 1993, Inhibitory effects of tea extracts and (−)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells, Cancer Lett., 68, 231, 10.1016/0304-3835(93)90151-X

Valcic, 1996, Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines, Anticancer Drugs, 7, 461, 10.1097/00001813-199606000-00011

D.A. Balentine, Manufacturing and chemistry of tea, in: C.T. Ho, M.T. Huang, C.Y. Lee (Eds.), Phenolic Compounds in Food and Their Effects on Health: Analysis, Occurrence, and Chemistry, Vol. 8, American Chemical Society, Washington, DC, 1992, pp. 102–117.

Gavrieli, 1992, Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation, J. Cell Biol., 119, 493, 10.1083/jcb.119.3.493

Chen, 1992, Mechanism of regulation of ornithine decarboxylase gene expression by asparagine in variant mouse neuroblastoma cell line, J. Biol. Chem., 267, 6946, 10.1016/S0021-9258(19)50520-8

Hayflick, 1965, The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9

Pang, 1996, The age-dependent binding of CBP/tk, a CCAAT binding protein, is deregulated in transformed and immortalized mammalian cells but absent in premature aging cells, Exp. Gerontol., 31, 97, 10.1016/0531-5565(95)02019-5

Hibasami, 1996, Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds, Anticancer Res., 16, 1943

G. Yang, J. Liao, K. Kim, E.J. Yurkow, C.S. Yang, Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols, Carcinogenesis (1998) in press.

White, 1996, Life, death, and the pursuit of apoptosis, Genes Dev., 10, 1, 10.1101/gad.10.1.1

Pandey, 1995, Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse, J. Cell. Biochem., 58, 135, 10.1002/jcb.240580203